Fluence Corporation Limited has reported significant growth in its financial performance for FY 2025, with a 52.3% increase in revenue reaching $78.4 million and an EBITDA of $4.0 million. The company is pivoting towards Smart Product Solutions and Recurring Revenue to improve margins and revenue sustainability. Key strategies include expanding in North America, leveraging strengths in Southeast Asia and China, and focusing on high-margin business segments. Fluence is successfully integrating its proprietary MABR technology in various projects and has a backlog of $64.4 million as of March 2026, indicating strong growth prospects. The company is also involved in substantial projects like the Ivory Coast water treatment plant, while aiming for double-digit EBITDA margins in the near future.
Key Points
Fluence Corporation Limited is experiencing significant growth in its core business units.
The company reported a 52.3% growth in revenue for FY 2025 over the previous year, reaching $78.4 million.
EBITDA for FY 2025 was reported as $4.0 million, a substantial increase from the previous year.
The company has strategically transitioned to focus on Smart Product Solutions (SPS) and Recurring Revenue (RR) to enhance margins and revenue quality.
Fluence's market strategy includes expanding operations in North America and leveraging its presence in Southeast Asia and China.
Fluence's proprietary Membrane Aerated Biofilm Reactor (MABR) technology is highlighted as a competitive advantage.
The company's backlog as of March 31, 2026, was $64.4 million, reflecting strong order intake and future growth potential.
Fluence is involved in major projects like the Ivory Coast water treatment plant, indicating its capability in handling large-scale operations.
The company is actively pursuing opportunities in high-margin segments and strategic acquisitions to support organic growth.
Fluence is aiming for double-digit EBITDA margins in the next 2-3 years through organic growth and operational efficiencies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.